Current and emerging medications for the management of obesity in adults

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)

Abstract

To the Editor: We congratulate Walmsley and Sumithran1 for their excellent review on medications for the management of obesity in adults. We also wish to highlight a safety signal for thyroid cancer with glucagon-like peptide 1 (GLP-1) receptor agonists, which is a relevant issue to prescribers given the widespread use of these agents for obesity.

Preclinical studies in rodents demonstrated that all GLP-1 receptor agonists caused thyroid C cell tumours...
Original languageEnglish
Pages (from-to)187
Number of pages1
JournalMedical Journal of Australia
Volume219
Issue number4
Early online date4 Jul 2023
DOIs
Publication statusPublished - Aug 2023

Keywords

  • adverse events
  • Cancer
  • Diabetes mellitus, type 2
  • Endocrine gland neoplasms
  • Obesity
  • Pharmaceuticals

Fingerprint

Dive into the research topics of 'Current and emerging medications for the management of obesity in adults'. Together they form a unique fingerprint.

Cite this